Clovis Oncology Inc reports results for the quarter ended in March - Earnings Summary

Clovis Oncology

04/05/2022 20:29

* Clovis Oncology Inc  CLVS.OQ  reported a quarterly
adjusted loss
of 44 cents​​ per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss
of 43 cents per share.
    * Revenue fell 10% to $34.25 million from a year ago; 
analysts
expected $36.98 million. 
    * Clovis Oncology Inc's reported EPS for the quarter was a
loss
of 44 cents​.
    * The mean earnings estimate of analysts had fallen by
about 18.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Clovis Oncology Inc shares had risen by 4.0% this
quarter and
lost 22.5% so far this year.
    * The company reported a quarterly loss of $60.17 million.
    * Wall Street's median 12-month price target for Clovis
Oncology
Inc is $4.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and 2 "sell" or "strong sell." 

This summary was machine generated May 4 at 07:29 p.m.  ​All
figures in US dollars unless otherwise stated